Sarana Meditama Revenue vs. Gross Profit
| SAME Stock | IDR 260.00 2.00 0.78% |
For Sarana Meditama profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sarana Meditama to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sarana Meditama Metropolitan utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sarana Meditama's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sarana Meditama Metropolitan over time as well as its relative position and ranking within its peers.
Sarana |
Sarana Meditama Metr Gross Profit vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sarana Meditama's current stock value. Our valuation model uses many indicators to compare Sarana Meditama value to that of its competitors to determine the firm's financial worth. Sarana Meditama Metropolitan is rated below average in revenue category among its peers. It also is rated below average in gross profit category among its peers fabricating about 0.41 of Gross Profit per Revenue. The ratio of Revenue to Gross Profit for Sarana Meditama Metropolitan is roughly 2.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sarana Meditama's earnings, one of the primary drivers of an investment's value.Sarana Revenue vs. Competition
Sarana Meditama Metropolitan is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 35.59 Trillion. Sarana Meditama holds roughly 1.27 Trillion in revenue claiming about 4% of equities under Health Care industry.
Sarana Gross Profit vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Sarana Meditama |
| = | 1.27 T |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Sarana Meditama |
| = | 518.68 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Sarana Gross Profit Comparison
Sarana Meditama is currently under evaluation in gross profit category among its peers.
Sarana Meditama Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sarana Meditama, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sarana Meditama will eventually generate negative long term returns. The profitability progress is the general direction of Sarana Meditama's change in net profit over the period of time. It can combine multiple indicators of Sarana Meditama, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PT Sarana Meditama Metropolitan Tbk, together with its subsidiaries, engages in the management of hospitals in Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Omni Health Care. Sarana Meditama is traded on Jakarta Stock Exchange in Indonesia.
Sarana Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sarana Meditama. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sarana Meditama position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sarana Meditama's important profitability drivers and their relationship over time.
Use Sarana Meditama in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sarana Meditama position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarana Meditama will appreciate offsetting losses from the drop in the long position's value.Sarana Meditama Pair Trading
Sarana Meditama Metropolitan Pair Trading Analysis
The ability to find closely correlated positions to Sarana Meditama could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sarana Meditama when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sarana Meditama - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sarana Meditama Metropolitan to buy it.
The correlation of Sarana Meditama is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sarana Meditama moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sarana Meditama Metr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sarana Meditama can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sarana Meditama position
In addition to having Sarana Meditama in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large & Mid Caps ETFs Thematic Idea Now
Large & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Sarana Stock
To fully project Sarana Meditama's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sarana Meditama Metr at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sarana Meditama's income statement, its balance sheet, and the statement of cash flows.